Meeder Advisory Services’s Biogen BIIB Stock Holding History

Meeder Advisory Services’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$866K	Buy	4,721 +57	+1%	+$10.5K	0.04%	302
2025 Q4	$821K	Buy	4,664 +290	+7%	+$47.4K	0.04%	309
2025 Q3	$613K	Buy	4,374 +165	+4%	+$22.3K	0.03%	351
2025 Q2	$529K	Buy	4,209 +2,599	+161%	+$324K	0.03%	364
2025 Q1	$220K	Buy	1,610 +218	+16%	+$31.2K	0.01%	526
2024 Q4	$213K	Sell	1,392 -130	-9%	-$21.9K	0.01%	526
2024 Q3	$295K	Sell	1,522 -429	-22%	-$89.8K	0.02%	441
2024 Q2	$452K	Buy	1,951 +422	+28%	+$91.7K	0.03%	339
2024 Q1	$330K	Sell	1,529 -159	-9%	-$37.2K	0.03%	337
2023 Q4	$437K	Sell	1,688 -6	-0.4%	-$1.47K	0.05%	287
2023 Q3	$435K	Sell	1,694 -417	-20%	-$112K	0.05%	284
2023 Q2	$601K	Buy	2,111 +126	+6%	+$37.5K	0.06%	254
2023 Q1	$552K	Buy	1,985 +287	+17%	+$79.4K	0.06%	259
2022 Q4	$470K	Buy	+1,698	New	+$480K	0.06%	271

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Meeder Advisory Services's BIIB Position: Q1 2026 in Review

Meeder Advisory Services increased its Biogen (BIIB) stake by 1.2% in Q1 2026, buying an estimated $10.5K and bringing the position to 4,721 shares worth $866K. The position accounts for 0.04% of the portfolio, ranked #302.

Meeder Advisory Services first reported a position in BIIB in Q4 2022 and has held it in 14 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

Meeder Advisory Services held 4,721 shares of Biogen worth $866K as of Q1 2026.
Meeder Advisory Services bought 57 Biogen shares in Q1 2026, an estimated $10.5K.
Biogen made up 0.04% of Meeder Advisory Services's portfolio in Q1 2026, its #302 holding.
Meeder Advisory Services first reported a position in Biogen in Q4 2022 and has held it in 14 quarters since.
1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.